Mr. Andrew J. Rae, MBA, is President, Chief Executive Officer and Director of iCo Therapeutics Inc. Mr. Rae is the Chief Executive Officer and President of the Company on a fulltime basis. Mr. Rae has spent a decade in the biotechnology industry, most recently as the chief financial officer of Ability Biomedical Corporationrationration, which was acquired by Medarex, Inc. in 2004. Mr. Rae has also served as vicepresident of finance and corporate affairs with Active Pass Pharmaceuticals, Inc. During his tenure at both Active Pass and Ability Biomedical, Mr. Rae raised approximately $20 million in the aggregate in venture financing, engaged in a crossborder acquisition transaction and played a role in shaping multiple business development deals. Before joining Active Pass, Mr. Rae served as a biotechnology equities analyst for Goepel Shields & Partners, where he covered Canadian biotechnology stocks including Angiotech Pharmaceuticals, Inc., QLT Inc. and ID Biomedical Corporationration Mr. Rae currently sits on the Dean External Advisory Board for the Faculty of Business Administration at Simon Fraser University, the Board of Directors of Biowest Therapeutics a biotechnology company in Vancouver, the BCIT/University of British Columbia BSc in Biotechnology, Honours Program Advisory Committee, and the Board of Directors of Covenant House Vancouver, a charity operating shelters and counsel to homeless youth in Vancouver, BC. In 2009 Andrew was Pacific Finalist, Ernst & Young Entrepreneur of the Year
Click "OK" to permanently delete this portfolio. Click "Cancel" if you have changed your mind.
Report was successfully generated.
You can either (1) right-mouth click the image to download it to your local drive or simply (2) copy and paste the
image data below to include picture of this graph on your web page without downloading the image file
Copy and paste above text right to your web page html
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide.
Please fill out our quick survey to help us provide your with a better service and user experience
Most of the functionality on our site is free to use.
However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented
capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory
AMEX International Coal Group Inc
0.17%
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
TSXV
